The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/38003
StudyName: Eligibility Breast Cancer NCT01432886
Date of export from the portal: 02.07.2020
Copyright Holder: See clinicaltrials.gov
Date of Upload / last change: 07.09.2019
License: Creative Commons BY 4.0

----

Description: 
A Study of Eribulin Mesylate With Trastuzumab for Advanced or Recurrent Human Epidermal Growth Factor Receptor 2-Positive (HER2+) Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01432886
